Illuminating the Druggable Genome (IDG) phase 2 kick-off
Mar 26, 2018
Alexander Junge
1 minute read

Two weeks ago, I attended the kick-off meeting of phase 2 of the Illuminating the Druggable Genome (IDG) program. A pdf of our poster presented at the meeting is available here.

The IDG program aims to shed light on understudied drug targets - proteins that are members of three protein families commonly targeted by drugs (G-protein coupled receptors, ion channels, protein kinases) that themselves have not attracted much research attention. The IDG Consortium is supported by the NIH’s Common Fund and my postdoctoral research is currently funded by the IDG grant. As our contribution to the program, we aim to use biomedical literature mining to shed light on understudied drug targets. One of the main results of the first phase of the IDG program is the knowledge portal Pharos.

After attending the kick-off meeting, we met with the group of Zhiyong Lu at the US National Library of Medicine (NLM) for a fruitful discussion of current research projects.

comments powered by Disqus